2 research outputs found
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A
In this 12-months study low-dose Cyclosporine A reduced the rate of further joint damage in previously involved joints as well as the rate of new joint involvement in previously non involved joints, in patients with early rheumatoid arthritis